Robinson James A. Jr. — SEC insider filings

SEC reporting owner CIK 1734295. 18 insider filings on record with FilingPulse; latest filed 2026-08-28.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-01-12 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
UroGen Pharma Ltd. (URGN)Director10——16
Eledon Pharmaceuticals, Inc. (ELDN)Director3——5
Urovant Sciences Ltd. (UROV)PEO;CEO/Urovant Sciences, Inc., Director2——5
Neos Therapeutics, Inc. (NEOS)Director1——3
APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Director2——2

Insider filings — Robinson James A. Jr.

FiledFormIssuerReported transactionsSource
2026-08-284UroGen Pharma Ltd. (URGN)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-06-244UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2026-05-274UroGen Pharma Ltd. (URGN)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-02-274UroGen Pharma Ltd. (URGN)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-01-164Eledon Pharmaceuticals, Inc. (ELDN)Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0EDGAR
2025-12-014UroGen Pharma Ltd. (URGN)Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2025-08-274UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2025-01-134Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 30,870 (derivative) @ $0 · Grant/award (A): 3,430 (derivative) @ $0EDGAR
2024-08-084UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-10-034Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 150,437 (derivative) @ $1.55EDGAR
2023-09-084UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-07-284/AUroGen Pharma Ltd. (URGN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-274UroGen Pharma Ltd. (URGN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-12-014APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Disposition to issuer (D): 25,000 (derivative)EDGAR
2021-12-024APPLIED GENETIC TECHNOLOGIES CORP (AGTC)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-03-314Urovant Sciences Ltd. (UROV)Disposition to issuer (D): 8,385 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 845,732 (derivative) @ $0EDGAR
2021-03-194Neos Therapeutics, Inc. (NEOS)Disposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-01-124Urovant Sciences Ltd. (UROV)Tax withholding (F): 4,095 @ $16.11EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734295 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs